Meryem Askın1, Esra Meltem Koc1, Kaan Sozmen2, Muzaffer Onur Turan3, Zeki Soypacacı4, Saliha Aksun5. 1. Izmir Katip Celebi University Faculty of Medicine - Department of Family Medicine, Izmir - Turquia. 2. Izmir Katip Celebi University Faculty of Medicine - Department of Public Health, Izmir - Turquia. 3. Izmir Katip Celebi University Faculty of Medicine - Department of Chest Diseases,Izmir - Turquia. 4. Izmir Katip Celebi University Faculty of Medicine - Department of Nephrology, Izmir - Turquia. 5. Izmir Katip Celebi University Faculty of Medicine - Department of Medical Biochemistry, Izmir - Turquia.
Abstract
BACKGROUND: Non-dipper blood pressure is defined by less than a 10% reduction in nighttime blood pressure, and it is associated with cardiovascular disease. Inflammation is thought to play a role in the pathogenesis of both chronic obstructive pulmonary disease (COPD) and non-dipper blood pressure pattern, and both diseases are associated with lower quality of life. OBJECTIVE: The aim of this study was to investigate the effects of non-dipper blood pressure pattern in patients with COPD. METHODS: A cross-sectional study was carried out with 142 patients with COPD. The Saint George Respiratory Questionnaire and the Euro Quality of Life Scale were used to collect data. To understand arterial stiffness, the augmentation index and pulse wave velocity were measured, and 24-hour ambulatory blood pressure monitoring was subsequently performed. A multivariable logistic regression model was used to understand the relationship between different independent variables and blood pressure pattern. P values lower than 0.05 were considered statistically significant. RESULTS: As a result, 76.1% (n = 108) of the patients had non-dipper blood pressure pattern. Non-dipper patients had higher C-reactive protein (OR:1.123; 95% CI:1.016;1.242), augmentation index (OR: 1.057; 95% CI: 1.011;1.105) and Saint George Respiratory Questionnaire total score (OR: 1.021; 95% CI: 1.001;1.042) than dipper patients. Also, as the number of people living at home increased, non-dipper blood pressure pattern was found to be more frequent (OR: 1.339; 95% CI: 1.009;1.777). CONCLUSION: Non-dipper blood pressure pattern may increase cardiovascular risk by triggering inflammation and may adversely affect the prognosis of COPD by lowering the disease-related quality of life. (Arq Bras Cardiol. 2020; [online].ahead print, PP.0-0).
BACKGROUND: Non-dipper blood pressure is defined by less than a 10% reduction in nighttime blood pressure, and it is associated with cardiovascular disease. Inflammation is thought to play a role in the pathogenesis of both chronic obstructive pulmonary disease (COPD) and non-dipper blood pressure pattern, and both diseases are associated with lower quality of life. OBJECTIVE: The aim of this study was to investigate the effects of non-dipper blood pressure pattern in patients with COPD. METHODS: A cross-sectional study was carried out with 142 patients with COPD. The Saint George Respiratory Questionnaire and the Euro Quality of Life Scale were used to collect data. To understand arterial stiffness, the augmentation index and pulse wave velocity were measured, and 24-hour ambulatory blood pressure monitoring was subsequently performed. A multivariable logistic regression model was used to understand the relationship between different independent variables and blood pressure pattern. P values lower than 0.05 were considered statistically significant. RESULTS: As a result, 76.1% (n = 108) of the patients had non-dipper blood pressure pattern. Non-dipperpatients had higher C-reactive protein (OR:1.123; 95% CI:1.016;1.242), augmentation index (OR: 1.057; 95% CI: 1.011;1.105) and Saint George Respiratory Questionnaire total score (OR: 1.021; 95% CI: 1.001;1.042) than dipperpatients. Also, as the number of people living at home increased, non-dipper blood pressure pattern was found to be more frequent (OR: 1.339; 95% CI: 1.009;1.777). CONCLUSION: Non-dipper blood pressure pattern may increase cardiovascular risk by triggering inflammation and may adversely affect the prognosis of COPD by lowering the disease-related quality of life. (Arq Bras Cardiol. 2020; [online].ahead print, PP.0-0).
Authors: Neila Anders Aidar; Márcio Alberto Carvalho da Silva; César Augusto Melo e Silva; Pedro Nery Ferreira Júnior; Paulo Tavares Journal: Arq Bras Cardiol Date: 2009-09 Impact factor: 2.000
Authors: Barış Kılıçaslan; Hüseyin Dursun; Sermin Kaymak; Mehmet Aydın; Cenk Ekmekçi; İbrahim Susam; Öner Özdoğan Journal: Turk Kardiyol Dern Ars Date: 2015-01
Authors: Margarethe E Wacker; Rudolf A Jörres; Annika Karch; Sarah Wilke; Joachim Heinrich; Stefan Karrasch; Armin Koch; Holger Schulz; Henrik Watz; Reiner Leidl; Claus Vogelmeier; Rolf Holle Journal: BMC Pulm Med Date: 2016-05-10 Impact factor: 3.317
Authors: Rafael Golpe; Alfonso Mateos-Colino; Ana Testa-Fernández; Marta Pena-Seijo; Manuel Rodríguez-Enríquez; Carlos González-Juanatey; Francisco J Martín-Vázquez; Antonio Pose-Reino; Nuria Domínguez-Pin; Nuria Garnacho-Gayarre; Luis A Pérez-de-Llano Journal: PLoS One Date: 2016-06-30 Impact factor: 3.240